Myka Labs
Myka Labs leverages advances in artificial intelligence and advanced sensor systems to develop innovative surgical solutions aimed at improving patient outcomes. Their key products include Glint(TM) catheters, which provide essential insights for surgeons and gastroenterologists during complex abdominal procedures. The company differentiates itself through its pioneering research and technology, which streamlines surgical procedures and enhances recovery times. With a focus on high-clinical-impact interventions, Myka Labs is positioned to make significant contributions in the fields of cancer treatment and congenital malformation repairs, demonstrating traction through successful applications in leading medical institutions.
Myka Labs
Myka Labs leverages advances in artificial intelligence and advanced sensor systems to develop innovative surgical solutions aimed at improving patient outcomes. Their key products include Glint(TM) catheters, which provide essential insights for surgeons and gastroenterologists during complex abdominal procedures. The company differentiates itself through its pioneering research and technology, which streamlines surgical procedures and enhances recovery times. With a focus on high-clinical-impact interventions, Myka Labs is positioned to make significant contributions in the fields of cancer treatment and congenital malformation repairs, demonstrating traction through successful applications in leading medical institutions.
TL;DR
Headquarters: San Francisco, California, United States
Founded: 2021
Sector: Medical devices (interventional/procedural for GI and other organs)
Notable product: Glint™ catheters (sensor-augmented interventional devices)
Investors / funding: Grant funding from Consortium For Technology & Innovation in Pediatrics; Thomas Fogarty Trust listed as investor
Company Overview
Problem Domain
Interventional/procedural technologies for gastrointestinal and other organ systems, with focus on high-clinical-impact abdominal and pediatric surgical conditions.
Founded
2021
Industry
Biotechnology
Funding Track Record
Recorded as a grant-style funding event on company profiles.
Investor Signal
“Thomas Fogarty Trust listed as an investor on company About page; Consortium For Technology & Innovation in Pediatrics recorded as grantor”